Hitomi Imachi
-
- Pituitary Gland Disorders and Treatments 12
- Growth Hormone and Insulin-like Growth Factors 12
- Cancer Research top 5%
- Surgery top 5%
- Cholesterol and Lipid Metabolism 18
- Pancreatic function and diabetes 16
- Adrenal and Paraganglionic Tumors 12
- Oncology top 10%
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 13
-
- Metabolism, Diabetes, and Cancer 15
- Peroxisome Proliferator-Activated Receptors 11
In The Last Decade
Hitomi Imachi
108 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 99
- Endocrinology, Diabetes and Metabolism 482
- Cancer Research 319
- Surgery 691
- Oncology 407
- Epidemiology 460
Countries citing papers authored by Hitomi Imachi
This map shows the geographic impact of Hitomi Imachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Imachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Imachi more than expected).
Fields of papers citing papers by Hitomi Imachi
This network shows the impact of papers produced by Hitomi Imachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Imachi. The network helps show where Hitomi Imachi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hitomi Imachi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2022 | 3 | |
| 3 | 2020 | 27 | |
| 4 | 2020 | 2 | |
| 5 | 2018 | 22 | |
| 6 | 2018 | 15 | |
| 7 | 2016 | 2 | |
| 8 | 2013 | 0 | |
| 9 | 2010 | 5 | |
| 10 | 2010 | 5 | |
| 11 | 2009 | 32 | |
| 12 | 2009 | 45 | |
| 13 | 2008 | 14 | |
| 14 | 2008 | 8 | |
| 15 | 2008 | 8 | |
| 16 | 2007 | 42 | |
| 17 | 2006 | 20 | |
| 18 | 2004 | 7 | |
| 19 | 2004 | 13 | |
| 20 | 2002 | 52 |
About Hitomi Imachi
Hitomi Imachi is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 112 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (18 papers), Pancreatic function and diabetes (16 papers), Metabolism, Diabetes, and Cancer (15 papers), Neuroendocrine Tumor Research Advances (13 papers), Pituitary Gland Disorders and Treatments (12 papers), Adrenal and Paraganglionic Tumors (12 papers), Growth Hormone and Insulin-like Growth Factors (12 papers) and Peroxisome Proliferator-Activated Receptors (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (482 citations), Cancer Research (319 citations) and Surgery (691 citations). Hitomi Imachi has collaborated with scholars based in Japan, Canada and China. Frequent co-authors include Koji Murao, Toshihiko Ishida, Makoto Sato, Norman C.W. Wong, Jiro Takahara, Wen Cao, Hisakazu Iwama, Xiao Yu, Hitoshi Hosokawa and Takamasa Nishiuchi. Their work appears in journals such as Endocrinology, Nutrients, FEBS Letters, Journal of Molecular Endocrinology and Hormone and Metabolic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.